Profile
OPTT is a digital mental health platform equipping healthcare organizations with a comprehensive package of digital telepsychiatry capabilities and intelligent solutions. The platform includes clinically validated pre-designed therapy content and analytical capabilities to offer their services online, at a fraction of the traditional cost and time. Rooted in evidence-based clinical research, OPTT combines medical-level precision with clinically validated psychotherapy techniques and machine learning algorithms to improve capacity and quality of care, improve access and affordability of continuous care.

Website
optt.caContact
-
Dr. Mohsen Omrani, President and Chief Executive OfficerTel: +1 845-633-4528Email: mohsen@optt.ca
Event details
Date: September 14 - 16, 2020
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
16 in total
-
Artenga’s microbubble drug conjugates (MDC) are used with focused ultrasound (FUS) as a key…
-
ChipCare is a Toronto-based pre-revenue company, developing a point-of-care platform which will have the unique…
-
Curiato is pioneering a non-invasive patient monitoring platform for healthcare. Our platform relies on our smart bed…
-
Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided…
-
KA Imaging has created color x-ray that allows for bone and soft tissue separation similar to CT, but at a fraction of…
-
The low-cost Lumasonix Blood Test (LBT) provides crucial information about otherwise undetectable cancer…
-
Mediphage Bioceuticals is a genetic medicine company developing safe, effective, and accessible cures for chronic and…
-
Nanology Labs has developed a tumor modulating theranostic agent, Manganescan, with capability to oxygenate tumors and…
-
OPTT is a digital mental health platform equipping healthcare organizations with a comprehensive package of digital…
-
Ovensa is a Canadian preclinical stage company developing a siRNA drug candidate silencing the overexpression of…
-
SaluTech has developed a proprietary conductive biomaterial (CBM) to treat patients suffering from Atrial…
-
The SWANglide ultrasound-enhanced needle biopsy from Swan Cytologics improves patient outcomes and reduces healthcare…
-
Thornhill Medical is a Canadian designer and manufacturer of innovative healthcare technology. Our product portfolio…
-
Ventripoint Diagnostics is a medical device company engaged in the development and commercialization of a breakthrough…
-
VeriLuce Therapeutics is an early-stage company currently focusing on the computational design and development of small…
-
Vitreo Pharma is a developmental stage company that utilizes a polypharmacology strategy to generate our lead, first-in…